Publications by authors named "Thomas Weimer"

Claim this Profile
I
Innovative spiral electrode configuration for enhancement of electrocoagulation-flotation.
Ehsan Jafari, M Reza Malayeri, Heike Brückner, Thomas Weimer, Peter Krebs

J Environ Manage· December 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Increased potency of recombinant VWF D'D3 albumin fusion proteins engineered for enhanced affinity for coagulation factor VIII.
Jenny Chia, Sabine Pestel, Isabelle Glauser, Kerstin Emmrich, Matthew P Hardy, Thomas Weimer

J Thromb Haemost· November 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Identification of a modified coagulation factor X with enhanced activation properties as potential hemostatic agent.
Mariana Ebert, Elmar Raquet, Sabine Schweisgut, Peter M Schmidt, Thomas Weimer

Blood Cells Mol Dis· July 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
F
FVIII half-life extension by coadministration of a D'D3 albumin fusion protein in mice, rabbits, rats, and monkeys.
Sabine Pestel, Hans-Wilhelm Beltz, Philipp Claar, Holger Lind, Marcel Mischnik, Thomas Weimer

Blood Adv· May 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The Coagulation Factor XIIa Inhibitor rHA-Infestin-4 Improves Outcome after Cerebral Ischemia/Reperfusion Injury in Rats.
Jennifer Krupka, Frauke May, Thomas Weimer, Ingo Pragst, Christoph Kleinschnitz

PLoS One· July 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
F
FXIIa inhibitor rHA-Infestin-4: Safe thromboprotection in experimental venous, arterial and foreign surface-induced thrombosis.
Frauke May, Jennifer Krupka, Marion Fries, Ina Thielmann, Ingo Pragst, Thomas Weimer

Br J Haematol· June 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
Non-clinical pharmacokinetics and pharmacodynamics of rVIII-SingleChain, a novel recombinant single-chain factor VIII.
Sabine Zollner, Elmar Raquet, Philipp Claar, Jochen Müller-Cohrs, Hubert J Metzner, Thomas Weimer

Thromb Res· July 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Preclinical efficacy and safety of rVIII-SingleChain (CSL627), a novel recombinant single-chain factor VIII.
Sabine B Zollner, Elmar Raquet, Jochen Müller-Cohrs, Hubert J Metzner, Thomas Weimer

Thromb Res· August 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
G
Genetic fusion to albumin improves the pharmacokinetic properties of factor IX.
Hubert J Metzner, Thomas Weimer, Ulrich Kronthaler, Wiegand Lang, Stefan Schulte

Thromb Haemost· October 2009

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Structure-function analysis of factor VII activating protease (FSAP): sequence determinants for heparin binding and cellular functions.
Lars Muhl, Karin Hersemeyer, Klaus T Preissner, Thomas Weimer, Sandip M Kanse

FEBS Lett· June 2009

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Prolonged in-vivo half-life of factor VIIa by fusion to albumin.
Thomas Weimer, Wilfried Wormsbächer, Ulrich Kronthaler, Wiegand Lang, Uwe Liebing

Thromb Haemost· April 2008

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The G534E polymorphism of the gene encoding the factor VII-activating protease is associated with cardiovascular risk due to increased neointima formation.
Daniel Sedding, Jan-Marcus Daniel, Lars Muhl, Karin Hersemeyer, Hannes Brunsch, Thomas Weimer

J Exp Med· December 2006

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Technical considerations for the performance of Nucleic acid Amplification Technology (NAT). The NAT Task Force Group.
Michael Chudy, Indira Hewlett, John Saldanha, Celso Bianco, Andrew J Conrad, Thomas Weimer

Biologicals· September 2003

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Marburg I polymorphism of factor VII--activating protease: a prominent risk predictor of carotid stenosis.
Johann Willeit, Stefan Kiechl, Thomas Weimer, Artur Mair, Peter Santer

Circulation· February 2003

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
Hepatitis A virus prevalence in plasma donations.
Thomas Weimer, Sigrid Streichert, Charles Watson, Albrecht Gröner

J Med Virol· August 2002

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis